---
title: Mechanism of action of specific pharmaceutical agents
videoId: SIdKlpcoqMo
---

From: [[marrowmed]] <br/> 

This article outlines the mechanisms of action for various pharmaceutical agents, as discussed in a pharmacology session covering recall MCQs from the November 2024 INI CET exam <a class="yt-timestamp" data-t="00:00:06">[00:00:06]</a>.

## Antiparasitic Drugs

*   **Albendazole**
    *   Effective against nematodes and cestodes (tapeworms) <a class="yt-timestamp" data-t="02:00:00">[02:00:00]</a>.
    *   Not effective against trematodes (flukes) <a class="yt-timestamp" data-t="02:06:00">[02:06:00]</a>.
*   **Triclabendazole**
    *   Specifically effective against the trematode *Fasciola hepatica* <a class="yt-timestamp" data-t="02:10:00">[02:10:00]</a>.
*   **Praziquantel**
    *   Used for all other trematodes <a class="yt-timestamp" data-t="02:13:00">[02:13:00]</a>.
*   **Chloroquine**, **Pyrimethamine**, **Artemether**, **Sulfadoxine-Pyrimethamine**
    *   All can be used in uncomplicated malaria <a class="yt-timestamp" data-t="04:18:00">[04:18:00]</a>.
*   **Primaquine**
    *   Used for the prevention of malaria relapse <a class="yt-timestamp" data-t="04:32:00">[04:32:00]</a>.
    *   Not used for symptomatic treatment of uncomplicated malaria <a class="yt-timestamp" data-t="05:05:00">[05:05:00]</a>.

## Cardiovascular Drugs

*   **Atorvastatin**
    *   A statin, used to decrease LDL cholesterol <a class="yt-timestamp" data-t="02:51:00">[02:51:00]</a>, but may not be sufficient to normalize high LDL levels in some cases <a class="yt-timestamp" data-t="02:58:00">[02:58:00]</a>.
*   **Ezetimibe**
    *   Used to decrease LDL cholesterol <a class="yt-timestamp" data-t="03:20:00">[03:20:00]</a>.
*   **Evap (likely Evolocumab or Alirocumab, PCSK9 inhibitors)**
    *   Used to decrease LDL cholesterol <a class="yt-timestamp" data-t="03:23:00">[03:23:00]</a>.
*   **Gemfibrozil**
    *   A fibrate, primarily used to decrease triglycerides, not LDL cholesterol <a class="yt-timestamp" data-t="03:27:00">[03:27:00]</a>.
*   **Bempedoic acid**
    *   Used to decrease LDL cholesterol <a class="yt-timestamp" data-t="03:33:00">[03:33:00]</a>.
*   **Alpha-blockers**
    *   Decrease diastolic blood pressure, though the effect may be minimal <a class="yt-timestamp" data-t="11:10:00">[11:10:00]</a>.
*   **Beta-1 Adrenergic Agonists**
    *   Increase cardiac contraction output <a class="yt-timestamp" data-t="10:57:00">[10:57:00]</a>.

## Antivirals (HIV)

*   **Ibalizumab**
    *   Binds to CD4, acting as a CD4 inhibitor <a class="yt-timestamp" data-t="05:32:00">[05:32:00]</a>.
    *   Has action on both CCR5 and CXCR4 tropic HIV infections <a class="yt-timestamp" data-t="05:24:00">[05:24:00]</a>.
    *   Administered intravenously <a class="yt-timestamp" data-t="06:01:00">[06:01:00]</a>.
*   **Maraviroc** and **Vicriviroc**
    *   CCR5 inhibitors <a class="yt-timestamp" data-t="05:39:00">[05:39:00]</a>.
*   **Elvitegravir**
    *   An integrase inhibitor <a class="yt-timestamp" data-t="05:45:00">[05:45:00]</a>.
*   **Naivir (e.g., Lopinavir, Ritonavir, Atazanavir)**
    *   Protease inhibitors <a class="yt-timestamp" data-t="05:48:00">[05:48:00]</a>.

## Antiepileptic Drugs

*   **Lacosamide**
    *   Acts on sodium channels by potentiating slow sodium inactivation <a class="yt-timestamp" data-t="06:11:00">[06:11:00]</a>.
    *   This mechanism blocks repetitive firing of neurons, making it effective for partial seizures <a class="yt-timestamp" data-t="06:42:00">[06:42:00]</a>.
*   **Lamotrigine**
    *   Has no effect on the slow inactivation of sodium channels <a class="yt-timestamp" data-t="07:06:00">[07:06:00]</a>.
*   **Phenytoin**
    *   Acute oral overdose primarily results in cerebellar and vestibular symptoms like ataxia, diplopia, and dysarthria <a class="yt-timestamp" data-t="14:14:00">[14:14:16]</a>.
    *   High doses have been associated with marked cerebellar atrophy <a class="yt-timestamp" data-t="14:28:00">[14:28:00]</a>.
    *   Intravenous administration at a rate greater than 50 mg/minute can lead to cardiac arrhythmias and CNS depression <a class="yt-timestamp" data-t="14:50:00">[14:50:00]</a>.
*   **Tiagabine**
    *   A GABA (gamma-aminobutyric acid) transporter inhibitor <a class="yt-timestamp" data-t="16:06:00">[16:06:00]</a>.
    *   Used for the treatment of partial seizures <a class="yt-timestamp" data-t="16:17:00">[16:17:00]</a>.

## Anticancer Drugs

*   **PARP Inhibitors (e.g., Rucaparib)**
    *   Inhibit Poly ADP-ribose Polymerase (PARP) <a class="yt-timestamp" data-t="07:25:00">[07:25:00]</a>.
    *   Rucaparib is approved for BRCA-positive breast cancer <a class="yt-timestamp" data-t="07:36:00">[07:36:00]</a>.
*   **Palbociclib**
    *   A CDK (cyclin-dependent kinase) 4 and 6 inhibitor <a class="yt-timestamp" data-t="07:54:00">[07:54:00]</a>.
    *   Used in breast cancer <a class="yt-timestamp" data-t="08:00:00">[08:00:00]</a>.
*   **Regorafenib**
    *   A BRAF inhibitor <a class="yt-timestamp" data-t="08:04:00">[08:04:00]</a>.
    *   Used in malignant melanoma <a class="yt-timestamp" data-t="08:08:00">[08:08:00]</a>.
*   **Vandetanib**
    *   An inhibitor of Vascular Endothelial Growth Factor (VEGF) or tyrosine kinase <a class="yt-timestamp" data-t="08:12:00">[08:12:00]</a>.

## Immunomodulators

*   **Tofacitinib**
    *   A Janus Kinase (JAK) inhibitor <a class="yt-timestamp" data-t="08:44:00">[08:44:00]</a>.
    *   Used for moderate to severe ulcerative colitis, especially when patients do not respond to anti-TNF alpha agents <a class="yt-timestamp" data-t="08:31:00">[08:31:00]</a>.
    *   Oral drugs <a class="yt-timestamp" data-t="09:09:00">[09:09:00]</a>.
*   **Baricitinib** and **Upadacitinib**
    *   Examples of other JAK inhibitors <a class="yt-timestamp" data-t="09:11:00">[09:11:00]</a>.

## Antitubercular Drugs

*   **Pretomanid**
    *   Belongs to the class of Nitroimidazole drugs <a class="yt-timestamp" data-t="12:57:00">[12:57:00]</a>.
    *   Produces free nitro anion radicals <a class="yt-timestamp" data-t="13:08:00">[13:08:00]</a>.
    *   Used for pre-XDR (extensively drug-resistant) TB, which is MDR (multi-drug resistant) plus fluoroquinolone resistance <a class="yt-timestamp" data-t="12:26:00">[12:26:00]</a>.
    *   Metabolized by microsomal enzymes, thus contraindicated with enzyme-inducing drugs <a class="yt-timestamp" data-t="12:41:00">[12:41:00]</a>.
    *   Used in BPaL (Bedanquiline, Pretomanid, Linezolid) regimen for pre-XDR TB <a class="yt-timestamp" data-t="13:28:00">[13:28:00]</a>.
    *   Also part of the BPaLM (Bedanquiline, Pretomanid, Linezolid, Moxifloxacin) regimen for MDR-TB <a class="yt-timestamp" data-t="13:40:00">[13:40:00]</a>.

## Antidotes

*   **Atropine**
    *   Antidote for organophosphorus poisoning <a class="yt-timestamp" data-t="10:09:00">[10:09:00]</a>.
*   **Physostigmine**
    *   Antidote for atropine poisoning <a class="yt-timestamp" data-t="10:17:00">[10:17:00]</a>.
*   **L-Carnitine**
    *   Antidote for valproate-induced hepatotoxicity <a class="yt-timestamp" data-t="10:20:00">[10:20:00]</a>.
*   **Flumazenil**
    *   Antidote for benzodiazepine overdose <a class="yt-timestamp" data-t="10:25:00">[10:25:00]</a>. [[mechanism_of_action_of_benzodiazepines_and_barbiturates | Benzodiazepines]]
*   **Deferoxamine**
    *   An iron chelating agent, not an antidote for arsenic <a class="yt-timestamp" data-t="10:29:00">[10:29:00]</a>.